ABBVIE revenue for the last year amounted to 49.21 B EUR, the most of which — 23.68 B EUR — came from its highest performing source at the moment, Immunology, the year earlier bringing 27.03 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought ABBVIE 37.95 B EUR, and the year before that — 42.71 B EUR.